Crossmark

Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice

Crossref DOI link: https://doi.org/10.1007/s12185-023-03541-x

Published Online: 2023-01-24

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mizuguchi, Makiko

Okamoto, Yasunobu

Yagi, Hikaru

Kagawa, Kumiko

Sekimoto, Etsuko

Shibata, Hironobu

Shigekiyo, Toshio

Ozaki, Shuji https://orcid.org/0000-0002-9808-0752
License Information

Text and Data Mining valid from 2023-01-24

Version of Record valid from 2023-01-24
More Information

Article History

Received: 8 November 2022

Revised: 11 January 2023

Accepted: 12 January 2023

First Online: 24 January 2023

Declarations

:

: The authors declare that there is no conflict of interest.

Document is current

Any future updates will be listed below